RT Journal Article
SR Electronic
T1 Investigating spatiotemporal patterns of the COVID-19 in São Paulo State, Brazil
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.28.20115626
DO 10.1101/2020.05.28.20115626
A1 Alcântara, Enner
A1 Mantovani, José
A1 Rotta, Luiz
A1 Park, Edward
A1 Rodrigues, Thanan
A1 Carvalho, Fernando Campos
A1 Filho, Carlos Roberto Souza
YR 2020
UL http://medrxiv.org/content/early/2020/05/30/2020.05.28.20115626.abstract
AB As of May 16th, 2020, the number of confirmed cases and deaths in Brazil due to COVID-19 hit 233,142 and 15,633, respectively, making the country one of the most affected by the pandemic. The State of Sao Paulo (SSP) hosts the largest number of confirmed cases in Brazil, with over 60,000 cases to date. Here we investigate the spatial distribution and spreading patterns of COVID-19 in the SSP by mapping the spatial autocorrelation and the clustering patterns of the virus in relation to the population density and the number of hospital beds. Moran’s I and LISA clustering analysis indicated that Sao Paulo City is a significant hotspot for both the confirmed cases and deaths, whereas other cities across the State could be considered colder spots. Bivariate Moran’s I also showed that the population density is a key indicator for the number of deaths, whereas the number of hospital beds is less related, implying that the fatality depends substantially on the actual patient’s condition. Social isolation measures throughout the SSP have been gradually increasing since early March, an action that helped to slow down the emergence of the new confirmed cases, highlighting the importance of the safe-distancing measures in mitigating the local transmission within and between cities in the SSP.Competing Interest StatementThe authors have declared no competing interest.Funding StatementE.A. and C.R.S.F. acknowledge the Brazilian National Council for Scientific and Technological Development (CNPq) for research grants 303169/2018-4 and 309712/2017-3, respectively.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No human data were used.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used are free and can be downloaded directly from: https://www.seade.gov.br/coronavirus/